Related Experiment Video
Updated: Jun 5, 2026
08:16
Generating Human Pancreatic Tissue Slices to Study Endocrine and Exocrine Pancreas Physiology
Published on: March 15, 2024
Fuelling the athlete with type 1 diabetes.
1Diabetes Centre, Wycombe Hospital, High Wycombe, Buckinghamshire HP11 2TT, UK. ian.gallen@buckshosp.nhs.uk
Diabetes, Obesity & Metabolism
|January 5, 2011
Summary
Managing type 1 diabetes (T1DM) during exercise requires understanding fuel metabolism to prevent hypoglycemia and hyperglycemia. This research proposes strategies to optimize athletic performance and glycemic control for athletes with T1DM.
Area of Science:
- Exercise physiology
- Metabolic regulation
- Diabetes management
Background:
- Athletes with type 1 diabetes (T1DM) face unique challenges managing their condition during physical activity.
- Understanding exercise physiology, particularly fuel mobilization and metabolism, is crucial for addressing these challenges.
Purpose of the Study:
- To explore the complexities of managing type 1 diabetes in the context of sports and exercise.
- To provide theoretical explanations for exercise-induced glycemic fluctuations (hypoglycemia and hyperglycemia).
- To propose management strategies for improving glycemic control and athletic performance in individuals with T1DM.
Main Methods:
- Review of exercise physiology principles related to fuel metabolism.
- Analysis of potential complications like hypoglycemia and hyperglycemia during exercise in T1DM.
- Development of theoretical frameworks for management strategies.
Main Results:
- Exercise physiology provides insights into potential diabetes management issues during physical activity.
- Specific circumstances can lead to hypoglycemia or hyperglycemia in athletes with T1DM.
- Theoretical explanations for these glycemic events are presented.
Conclusions:
- Effective management strategies can be developed based on physiological understanding.
- Dietary advice is essential for maximizing performance and minimizing fatigue.
- Proposed strategies aim to enhance both glycemic control and athletic performance for individuals with type 1 diabetes.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...